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Abstract
Several questions remain unanswered regarding the roles and interactive dynam-
ics of reactive oxygen species (ROS) and lipids/adipocytes. ROS have been con-
ventionally associated with deleterious effects in biological systems, especially 
correlated with metabolic disorders exemplified by diabetes, obesity, cancer, ath-
erogenesis, etc. Adipocytes, originally perceived as mere lipid-storing cells, were 
also associated with such metabolic disorders. In later times, adipose tissue was 
shown to have several favorable metabolic and physiological functions. Similarly, 
ROS were also acknowledged with favorable roles in cellular signaling. Very recent-
ly, ROS have been shown to be indispensable protagonists of key life-sustaining 
routines such as oxidative phosphorylation, thermogenesis and xenobiotics’ me-
tabolism. In the light of these developments, herein, we attempt to address why 
different research groups derive data that project/infer contrasting correlations of 
ROS and lipids with good health. We advocate that rather than seeing ROS and fat 
deposition as deleterious to health, the modality of their generation, loci of pres-
ence and the relative amounts/distribution in milieu are the crucial factors that 
determine their interactions/roles (and thereby, the resulting physiology!) in mis-
cellaneous microenvironments. 
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Introduction
For decades, ROS (reactive oxygen spe-
cies) have been seen as toxic and waste-
ful byproducts of biological processes 
like oxidative phosphorylation and xe-
nobiotic metabolism. The research for 
anti-oxidants (molecules that scavenged 
ROS) gained momentum due to the cor-
relation of ROS in cancer progression, 
ageing, apoptosis and oxidative damage 
to genes and proteins (1-2). Similarly, 
fatty tissue and free-lipid deposition 
were seen to have primarily negative 
connotations towards maintenance of 
good health (3). In recent times, the 
perceptions in the pertinent field of 
ROS-lipid interactions have undergone 
significant changes and this write-up 
aims to capture the salient aspects of the 
interactive dynamics of ROS and lipids/
adipocytes.  
Various ROS and their well-studied 
roles
ROS (reactive oxygen species), consti-
tutes a set of “atom-molecule-ion-rad-
ical” entities derived from the normal 
triplet molecular dioxygen, which is the 
abundant species present in atmosphere. 
This common oxygen species, 3O2, is 
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thus represented because the presence of two unpaired elec-
trons in the bonded structure gives a “triplet spin multiplicity” 
spectroscopic signature when a magnetic field is applied. Due to 
“spin rules”, the triplet oxygen does not pose high reactivity with 
most biomolecules. Table 1 provides the details of oxygen and 
its derivatives that form the simplest classes of ROS. Besides the 
ones listed below, ozone (O3, or trioxygen, a neutral triatomic 
molecule) and various other species incorporating nitrogen (e.g. 
nitric oxide, peroxynitrite), halogen (e.g. hypochlorous acid, 
chlorite, etc.), carbon (of the nature- RO*, ROO*, etc.) atoms, 
are also examples of more diverse types of ROS encountered in 
biological systems. 
Of all the ROS species, the superoxide ion radical is the one 
most abundantly found in physiological pH and can also exist as 
hydroperoxyl radical which can, more easily, percolate through 
the phospholipid bilayer. Hydroxyl radical is a very highly re-
active species that can damage nucleic acids, peptides and li-
pids severely. Hydrogen peroxide is relatively less reactive and 
formed mostly from the reaction of superoxide with the enzyme 
superoxide dismutase. Peroxide can cause damage to DNA by 
producing the hydroxyl radical. Singlet oxygen (1O2) is deemed 
to be extremely toxic and can cause DNA and tissue level dam-
age. It is mostly produced during neutrophil activation. Ozone 
(O3) is produced during inflammatory process in vivo and can 
be a strong oxidizing agent forming reaction intermediates with 
biological molecules that may lead to aberrations. Such patho-
physiological interactions of ROS with biological molecules 
have been well documented in scientific literature (4-11). In the 
last couple of decades, the roles of ROS as molecular signals/
messengers have been reported, explored and some cases like 
NO have been well-established (12-17).
Types of adipocytes and their perceived functions 
Adipocytes are cells that store excess energy (lipid reserves) in 
the form of triglycerides and tissues incorporating such cells 
also provide mechanical support and insulation to organisms. 
Recently, adipose tissue is also considered a major endocrine 
and paracrine organ of the human organism. A typical demar-
cation of adipose tissue based on its coloration divides it into 
2 types: brown adipose tissue (BAT) and white adipose tissue 
Table 1. Electronic distribution and naming conventions of select oxygen-centered species
Oxygen species Notation Stature (charge) & relevant pKa (if any) Electronic orbitals 
Triplet Oxygen 3O2 Diatomic diradical molecule (0). (Normal dioxygen) ↑↓ ↑↓ ↑↓ ↑↓ ↑↓ ↑ ↑
Oxygen O Atom (0); transient and very reactive ↑↓ ↑↓ ↑↓
Singlet Oxygen 1O2 Diatomic molecule (0)
(Excited dioxygen; more reactive to organics than 
singlet oxygen)
↑↓ ↑↓ ↑↓ ↑↓ ↑↓ ↑↓
Superoxide O2
*- Diatomic radical ion (-); becomes triatomic 
perhydroxyl/hydroperoxyl uncharged radical on 
protonation at pH 4.8. (Protonated species more 
reactive to organics than superoxide ion.)
↑↓ ↑↓ ↑↓ ↑↓ ↑↓ ↑↓ ↑
Peroxide H2O2 Tetra-atomic molecule (0); somewhat reactive, 
becomes triatomic hydroperoxide ion on 
deprotonation at 11.7.
↑↓ ↑↓ ↑↓ ↑↓ ↑↓ ↑↓ ↑↓
Hydroxyl OH* Di(hetero)atomic uncharged radical (0), one of the 
most reactive species known, 11.5. Deprotonated 
species (O*-) less reactive.
↑↓ ↑↓ ↑↓ ↑
Hydroxide OH- Di(hetero)atomic ion (-); not very reactive, becomes 
triatomic water molecule on protonation.
↑↓ ↑↓ ↑↓ ↑↓
Oxide O2- Monoatomic ion (--) ↑↓ ↑↓ ↑↓ ↑↓
Water H2O Triatomic molecule (0), 14. ↑↓ ↑↓ ↑↓ ↑↓
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(WAT). The multilocular BAT contains lower levels of lipids and 
more number of mitochondria when compared to WAT (18). 
Brown adipose tissue was earlier perceived as specific to infants 
and rodents as a site for non-shivering thermogenesis but re-
cent finds have revealed its presence in adult humans as well. 
The mechanism of thermogenesis in BAT was essentially under-
stood to be owing to two phenomena: lipolysis and dissipation 
of transmembrane potential formed by proton pumps in mito-
chondrial membrane (19). Some WAT undergo browning and 
are called “inducible, beige, or brite” adipose tissue (20). Figure 1 
shows the schematic differentiation of the three types of adipose 
cells/tissues. However, recent studies also show that adipose tis-
sue is not homogenous and varies in their metabolic profiles by 
depot-specificity and location (21). At present, it is not exactly 
clear how the various genetic and hormonal controls achieve the 
switching of different types of adipose tissues.
An update on the origin and relevance of ROS  
in biological systems 
Several external agents are known to act as sources that lead to 
generation of ROS, as shown in the top panel of Figure 2. The 
parsing of these agents is into three types – physical, chemical 
and foodstuff. External physical agents like various high-energy 
photons (of X-rays, cosmic rays, gamma rays, UV-light, etc.) 
and ionizing radiations (like alpha and beta rays) could impart 
sufficient energy for molecular breakage at various sites, lead-
ing to the generation of various radicals and ROS within (22-
23). Chemicals like natural alkaloids, xenobiotics like halogen-
ated organics, heavy metals and their salts, etc. are known ROS 
generators. Besides, foodstuff as exemplified by processed meat, 
used oil, alcoholic beverages, etc. are also known to lead to ROS 
generation. The function of ROS within the organism has been 
viewed under two lights- primarily pathological implications 
(immune responses, phagocytosis, and several diseases/disor-
ders) and secondarily for the purpose of molecular signaling 
(like nitric oxide, superoxide, etc.). The internal sites/organelles 
where ROS generation is known to be high are- mitochondria, 
endoplasmic or sarcoplasmic reticulum, and peroxisomes. This 
is the classical way of seeing ROS dynamics with respect to its 
interaction with various agents.   
Our group’s research works have dwelled on the utility of 
ROS as an electron transfer and group transfer agent in rou-
tine metabolism. We have shown that ROS and diffusible spe-
cies are responsible for electron/moiety transfers seen in heme/
flavin enzymes mediated reactions (24-35), which explain the 
metabolism of xenobiotics in hepatocyte endoplasmic reticulum 
Figure 1. Schematic rendition of the different types of adipocytes 
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(microsomes) (36-38), oxidative phosphorylation in mitochon-
dria (39-41), thermogenesis mediated by uncoupling proteins 
in BAT (41-42), and maverick physiological dose responses (35, 
43). This new metabolic/physiological paradigm that invokes 
reactions mediated via diffusible reactive species was recently 
called murburn concept (34-41, 43). Therefore, it is now defini-
tive that production of ROS in cellular systems cannot be seen 
as a pathological or cellular signaling process alone. The genera-
tion and utilization of ROS should now be seen as an obligatory 
“catalytic outcome” that resulted due to evolutionary pressures. 
This is because cells evolved to capitalize on the fast reactions 
mediated by oxygen centered radicals and the high potentials of 
these radicals could activate even non-activated carbons, ena-
bling facile metabolism. The predominantly hydrophobic organ-
ic molecules in the lipid cellular membranes would have high 
adsorption for the organic molecules. Retention of these mol-
ecules would progressively destroy cell structure and function. 
So, the generation of ROS enabled the attack on these xenobiot-
ics or alien molecules, thereby rendering them polar (as a hy-
droxyl group is introduced) and that would in turn be subjected 
to a “cleansing out” by water, the solvent of life. If ROS were to be 
bad, we cannot explain why millions of years of evolution could 
not bring about the structural mandates so that the “deleterious 
and chaotic” ROS were not produced by the proteins/organelles 
of prokaryotes and eukaryotes. 
Therefore, a more holistic functional classification for ROS 
dynamics is presented within the bottom panel of Figure 2. The 
new perspective is captured by three “actions”- introduction, in-
duction and production. ROS can be directly introduced into 
the living system (via smoke or tissue burning) or indirectly in-
duced within the organism by an exposure to physical agents 
(like high-energy or ionizing radiations). Internal (in situ or in 
Figure 2. ROS dynamics within cells: conventional and updated perceptions
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vivo) metabolism of several molecules occurs with the obligatory 
production and utilization of ROS at mitochondria, endoplas-
mic/sarcoplasmic reticulum, peroxisomes, etc. Therefore, ROS 
production within cells is no more to be seen as a pathological 
attribute (wasteful or toxic side-product). However, this is not 
to say that ROS is always beneficial. This metabolic facet is both 
physiological and at times, could end up being pathological. Just 
like any radical with high reaction potential, ROS is also capa-
ble of grave damage to living systems. The paradigm change of 
ROS from being a villain (pathological effects), to the side-kick 
(cellular messenger) and finally to a benevolent cum indispen-
sable protagonist (catalytic agent) is evident with the analysis of 
scientific literature through the past decades (13, 40-41, 43-46).
The perception of functional roles played by free-lipids 
and lipid-laden cells/tissues
Just like the change in perceptions on ROS, the case of adipose 
tissue has also undergone a radical change over the decades. 
Adipose tissue was also seen under negative light with increas-
ing incidence of obesity and associated metabolic pathology (18, 
47). However, recently, adipocytes have been acknowledged for 
their role in nutrient homeostasis, energy balance and release of 
adipokines, endocrine signaling molecules and protein factors 
(18, 48- 50). Also, it is known that Eskimos eat animal blubber 
in huge amounts, and they still have a long, active and healthy 
life. While low density lipoproteins are deemed bad, high den-
sity lipoproteins are good. Therefore, lipids and their storage de-
pots (adipocytes), per se, cannot be bad for health. Lipids (and 
not protein-capsids or glycan-walls!) evolved as the fundamen-
tal biological membrane choice because of its inherent fluidity 
and electron-rich nature that could form organized structures 
and embed proteins. The obligatory requirement and favorable 
roles of lipids in life is endorsed by the finding that animals even 
evolved to have a separate sense of taste for “fats” (51).
Therefore, the consensus is emerging that nutrient intake, ge-
netic make-up and idiosyncratic metabolic disposition is need-
ed to make a call on the “goodness” or “badness” of free-lipids 
and lipid-laden cells in a case-wise manner. More evaluation on 
how various cells, biomolecules and reactive species interact/re-
act with adipocytes is necessary for us to understand the latter’s 
role in pathology and physiological cascades. This could perhaps 
enable an adipose-tissue directed pharmacotherapy also (52).
Addressing the problematic ROS-lipid (adipocyte) 
interaction dynamics 
There is a plethora of data supporting the malevolent role of 
ROS in several diseases. However, several other research groups 
have published data which support beneficial roles of ROS in 
those same diseases. 
From the broad perceptions that ROS causes deterioration of 
lipids and lipid membranes, we now have specific information 
on how ROS react with lipid targets. These reactions most of-
ten lead to lipid peroxidations (9) which generates products like 
RCCs (reactive carbonyl compounds), alkanes and ketones. In 
turn, these products form cross-links and adducts with cellular 
constituents to form end products referred to as advanced lipid 
peroxidation end products (ALEs) (8). The RCCs can be further 
classified under three major groups (53):
1. the α,β-unsaturated aldehydes like 4-hydroxy-2-nonenal 
(4-HNE) and acrolein 
2. di-aldehydes like malondialdehyde and glyoxal
3. cheto-aldehyde (methylglyoxal) and isoketals (levuglan-
dins) 
Some of these molecular species (as exemplified in 1 & 2 
above) are implicated in artherosclerosis, chronic renal fail-
ure (54-58), neurodegenerative diseases like Alzheimers, 
Parkinsons, etc., (59-60), carcinogenesis (61-63) and chronic in-
flammatory diseases (64, 65, 66). All these diseases could poten-
tially involve adverse ROS-lipid interactions. While species such 
as 4-HNE are implicated in disease and cell death, it should also 
be noted that evidence is also available where 4-HNE promotes 
cell survival and signaling in gene expression, antioxidant ca-
pacity, adaptive response and effect anti-cancer properties (67-
71). It was argued therein that the outcomes depend on cellular 
metabolic circumstances and cell type, etc (72). Therefore, it can 
be seen that the interaction of ROS with adipocytes (and lipids 
therein) can also lead to positive effects. 
Similarly, in some research studies, ROS are assigned a vil-
lainous role in the development of atherosclerosis or plaque for-
mation in arteries (a condensed deposition of free lipids, calcium 
and miscellaneous substances that blocks the free flow of blood) 
(73-74). Nevertheless, in another study, Nox4, a ROS generating 
enzyme is implicated in anti-atherosclerotic function (75).
The same is the case for adipocytes. Some research groups 
provide evidence where adipocytes induce oxidative stress 
through release of ROS and ROS-inducing factors (76-79) and 
other groups give evidence of beneficial role of adipocytes in 
nutrient homeostasis, energy balance and release of endocrine 
signaling molecules and protein factors (18, 49, 50). 
Though the distribution and dynamics of ROS have been 
studied in lipid bilayers (80), the real-time detection and quan-
tification of various ROS (and their metabolic intermediates) 
is a major experimental challenge, as these species have highly 
dynamic and interactive equilibriums with their surrounding 
entities. Various labs use different probes with different settings. 
So, this could also lead to a major reason of disagreement be-
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tween various research groups, and this predicament stands to 
pose significant problems in the times to come. Moving on, if 
we look at the conflicting research data presented, it is evident 
that ROS is benevolent when present in mild to moderate levels 
in specific loci and malevolent when present in high concen-
trations or in undesired loci. In this light, murburn concept, a 
new mechanistic paradigm, addresses the catalysis mediated by 
in situ generated ROS and diffusible reactive species (34-41, 43). 
This stochastic paradigm can give both selective/ordered reac-
tions, and can also be subjected to fair amounts of uncertainties/
chaos by the presence of trace amounts of additives. Therefore, 
the amphipathic lipids and their derivatives can give concentra-
tion-dependent and contrasting outcomes between systems and 
experimental setups. We have demonstrated some of the com-
plex effects, underpinning mechanistic principles and constitu-
tive controls (32, 35-36,43). In the murburn perspective, besides 
the classical affinity-based interactions, other facets like dynam-
ic partitioning, relative concentrations, reaction microenviron-
ments’ dielectrics, availability of protons, spin state of reacting 
species, etc. are slated to be key governing constitutive principles 
that determine reaction outcomes (kinetics, stoichiometry, etc.). 
While it is clear how high amount of ROS can lead to delete-
rious effects, the tissue/loci-specific role change of ROS needs 
special attention, in the light of the contrasting findings and the 
possible explanations that murburn concept can afford. It has 
been proposed that timing, source and tissue specific effects of 
ROS would be beneficial in understanding the discrepancy of 
evidence presented in basic research and clinical studies (81). 
The tissue that is most evidently associated with ROS produc-
tion and interaction is adipose tissue. Hence it is most impor-
tant to keep murburn concept in perspective and examine the 
action of ROS within and outside adipose tissue to understand 
how ROS can have both deleterious and beneficial effects with 
respect to its location. 
There is also emerging evidence that cellular liquid phases 
have membrane-less aggregates that compartmentalize mol-
ecules based on their chemical and physical properties. These 
structural aggregations also serve several functional attributes 
of the cell (82-85). We project that ROS-lipid interactive dynam-
ics could affect such aggregations, thereby affecting normal or 
pathological physiology. For now, it is evident that the earlier 
viewpoints need to be revamped to accommodate the diverse 
set of experimental observations available. Clearly, not just in 
peroxisomes and phagocytes, ROS has an obligatory physiologi-
cal role in mitochondria and the membranous cytoplasmic/
sarcoplasmic reticulum. Therefore, ROS can no more be seen 
as a wasteful or toxic byproduct. Figure 3 captures the essen-
tial shift in perspective in this regard. As seen, lipids and lipid-
laden tissues serve the function of retaining integrity, affording 
a platform for ROS reactions, and enable conservation of heat 
Figure 3. The interaction paradigms of ROS and lipids/adipocytes
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by virtue of low heat capacity of oils (in comparison to water). It 
must be remembered that heat energy is one of the unsung he-
roes of metabolism- kinetics depend crucially on temperature! 
With these fundamental outlooks, reoriented research agenda 
can generate better understanding.
Conclusion
To recapitulate- it is true that DROS are implicated in oxida-
tive stress, several diseases and pathophysiological states. It is 
also true that enzymes like catalase, peroxidase, SOD, etc. de-
plete DROS and some antioxidants alleviate harmful effects of 
DROS. However, in physiology, any entity has its utility with 
respect to the context of location, time and quantity. Our works 
have clearly shown that the aqueous phase redox enzymes (cited 
above) cannot compete for the small amounts of DROS dynami-
cally generated at the phospholipid interface. Further, the ther-
modynamic, kinetic and reaction chemistry logic strongly en-
dorse the utility of DROS in several metabolic and physiological 
processes. Just because a cut-injury in the kitchen most probably 
results from knife-abuse, one does not infer that knives do not 
have any positive role in the kitchen! Also, one may find gloves 
and cutting-boards to hold and handle knives in the kitchen. 
Their presence too does not imply that knives have no construc-
tive culinary roles! (In this analogy- knives, gloves and cutting 
boards are equivalent to DROS, redox enzymes and antioxidants 
respectively.)  
    In the light of a plethora of emerging experimental evidences 
and theoretical insights, we should also acknowledge DROS’ 
roles as catalysts and protagonists in cellular metabolism, ho-
meostasis, energetics, and signaling. 
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